Search research articles
Contact Us
Filters
Showing results (211-220 of 276) with videos related to
Page
of 28
Sort By:
Journal for Immunotherapy of Cancer
|
May 25, 2023
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Clémence Demerlé, Laurent Gorvel, Marielle Mello, et al.
Communications Medicine
|
February 11, 2026
Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomy
Jonathan Garnier, Grégoire Bellan, Anaïs Palen, et al.
Journal of Clinical Immunology
|
February 10, 2012
Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy
Caroline Veuillen, Thérèse Aurran-Schleinitz, Rémy Castellano, et al.
Frontiers in Immunology
|
January 27, 2025
CD56<sup>neg</sup> CD16<sup>+</sup> cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML
Julia Wlosik, Florence Orlanducci, Manon Richaud, et al.
Cancer Research
|
October 3, 2012
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells
Julien Faget, Nathalie Bendriss-Vermare, Michael Gobert, et al.
The Journal of Infectious Diseases
|
April 1, 2024
Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19
Laetitia Gay, Marie-Sarah Rouviere, Soraya Mezouar, et al.
Cancer
|
February 11, 2004
Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus
Régis T Costello, Hacène Zerazhi, Aude Charbonnier, et al.
Experimental Hematology
|
October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen
Catherine Faucher, Mohamad Mohty, Norbert Vey, et al.
Clinical & Translational Immunology
|
August 10, 2017
NKG2C<sup>+</sup> memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
Françoise Gondois-Rey, Antoine Chéret, Samuel Granjeaud, et al.
Cancer Research
|
June 2, 2016
Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy
Kieu-Suong Le, Marie-Laure Thibult, Sylvain Just-Landi, et al.
Page
of 28
Search research articles
Search
Showing results (211-220 of 276) with videos related to
Sort By:
Page
of 28
Journal for Immunotherapy of Cancer
|
May 25, 2023
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Clémence Demerlé, Laurent Gorvel, Marielle Mello, et al.
Communications Medicine
|
February 11, 2026
Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomy
Jonathan Garnier, Grégoire Bellan, Anaïs Palen, et al.
Journal of Clinical Immunology
|
February 10, 2012
Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy
Caroline Veuillen, Thérèse Aurran-Schleinitz, Rémy Castellano, et al.
Frontiers in Immunology
|
January 27, 2025
CD56<sup>neg</sup> CD16<sup>+</sup> cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML
Julia Wlosik, Florence Orlanducci, Manon Richaud, et al.
Cancer Research
|
October 3, 2012
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells
Julien Faget, Nathalie Bendriss-Vermare, Michael Gobert, et al.
The Journal of Infectious Diseases
|
April 1, 2024
Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19
Laetitia Gay, Marie-Sarah Rouviere, Soraya Mezouar, et al.
Cancer
|
February 11, 2004
Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus
Régis T Costello, Hacène Zerazhi, Aude Charbonnier, et al.
Experimental Hematology
|
October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen
Catherine Faucher, Mohamad Mohty, Norbert Vey, et al.
Clinical & Translational Immunology
|
August 10, 2017
NKG2C<sup>+</sup> memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
Françoise Gondois-Rey, Antoine Chéret, Samuel Granjeaud, et al.
Cancer Research
|
June 2, 2016
Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy
Kieu-Suong Le, Marie-Laure Thibult, Sylvain Just-Landi, et al.
Page
of 28